*
|
|
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
|
1.
|
Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only):
|
|
|
|
|
|
BIOeCON B.V.
|
|
|
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions):
|
|
|
(a) o
|
|
|
(b) o
|
|
3.
|
SEC Use Only
|
|
4.
|
Source of Funds (See Instructions): OO
|
|
5.
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e): N/A
|
o
|
6.
|
Citizenship or Place of Organization: The Netherlands
|
|
Number of
|
7.
|
Sole Voting Power: 0
|
Shares
|
|
|
Beneficially
|
8.
|
Shared Voting Power: 5,146,599 *
|
Owned by
|
|
|
Each
|
9.
|
Sole Dispositive Power: 0
|
Reporting
|
|
|
Person
|
10.
|
Shared Dispositive Power: 0
|
With
|
|
|
11.
|
Aggregate Amount Beneficially Owned by Each Reporting Person: 5,146,599 *
|
|
12.
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions): N/A
|
o
|
13.
|
Percent of Class Represented by Amount in Row (11): 8.06%*
|
|
14.
|
Type of Reporting Person (See Instructions): CO
|
|
*
|
The amount of securities beneficially owned represents 5,146,599 shares of Class A Common Stock held by BIOeCON B.V. BIOeCON B.V. may be deemed to share voting power over these shares with BIOeCON Holding B.V., its controlling stockholder and BIOeCON International Holding N.V., the controlling stockholder of BIOeCON Holding B.V. Percentage ownership is calculated based on 63,847,951 shares of Class A Common Stock issued and outstanding, as reported on the Definitive Proxy Statement filed by KiOR, Inc. with the Securities and Exchange Commission on June 25, 2014.
|
1.
|
Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only):
|
|
|
|
|
|
BIOeCON Holding B.V.
|
|
|
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions):
|
|
|
(a) o
|
|
|
(b) o
|
|
3.
|
SEC Use Only
|
|
4.
|
Source of Funds (See Instructions): N/A
|
|
5.
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e): N/A
|
o
|
6.
|
Citizenship or Place of Organization: The Netherlands
|
|
Number of
|
7.
|
Sole Voting Power: 0
|
||
Shares
|
|
|
||
Beneficially
|
8.
|
Shared Voting Power: 5,146,599 *
|
||
Owned by
|
|
|
||
Each
|
9.
|
Sole Dispositive Power: 0
|
||
Reporting
|
|
|
||
Person
|
10.
|
Shared Dispositive Power: 0
|
||
With
|
|
|
11.
|
Aggregate Amount Beneficially Owned by Each Reporting Person: 5,146,599 *
|
|
||
12.
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions): N/A
|
o
|
||
13.
|
Percent of Class Represented by Amount in Row (11): 8.06%*
|
|
||
14.
|
Type of Reporting Person (See Instructions): CO
|
|
*
|
The amount of securities beneficially owned represents 5,146,599 shares of Class A Common Stock held by BIOeCON B.V., of which BIOeCON Holding B.V. is a controlling stockholder and therefore may be deemed to share voting power with BIOeCON B.V. over the shares.
|
1.
|
Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only):
|
|
|
|
|
|
BIOeCON International Holding N.V.
|
|
|
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions):
|
|
|
(a) o
|
|
|
(b) o
|
|
3.
|
SEC Use Only
|
|
4.
|
Source of Funds (See Instructions): N/A
|
|
5.
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e): N/A
|
o
|
6.
|
Citizenship or Place of Organization: Curacao, Netherlands Antilles
|
|
Number of
|
7.
|
Sole Voting Power: 0
|
||
Shares
|
|
|
||
Beneficially
|
8.
|
|||
Owned by
|
|
|
||
Each
|
9.
|
Sole Dispositive Power: 5,146,599 *
|
||
Reporting
|
|
|
||
Person
|
10.
|
Shared Dispositive Power: 0
|
||
With
|
|
|
11.
|
Aggregate Amount Beneficially Owned by Each Reporting Person: 5,146,599 *
|
|
||
12.
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions): N/A
|
o
|
||
13.
|
Percent of Class Represented by Amount in Row (11): 8.06%*
|
|
||
14.
|
Type of Reporting Person (See Instructions): CO
|
|
*
|
The amount of securities beneficially owned represents 5,146,599 shares of Class A Common Stock held by BIOeCON B.V., of which BIOeCON International Holding N.V. controls as the controlling stockholder of BIOeCON Holding B.V. BIOeCON International Holding N.V. has sole dispositive power over the shares, and may be deemed to share voting power.
|
Date
|
Shares
|
Price per Share
|
3/27/2014
|
50,000
|
$0.38
|
3/28/2014
|
50,000
|
$0.37
|
5/23/2014
|
10,000
|
$0.52
|
5/28/2014
|
10,000
|
$0.55
|
6/4/2014
|
10,000
|
$0.41
|
6/9/2014
|
10,000
|
$0.44
|
6/11/2014
|
10,000
|
$0.41
|
6/12/2014
|
10,000
|
$0.42
|
6/13/2014
|
10,000
|
$0.41
|
6/16/2014
|
10,000
|
$0.41
|
6/17/2014
|
10,000
|
$0.40
|
6/18/2014
|
20,000
|
$0.40
|
6/19/2014
|
20,000
|
$0.38
|
Date
|
Shares
|
Price per Share
|
6/20/2014
|
40,000
|
$0.36
|
6/23/2014
|
50,000
|
$0.36
|
6/24/2014
|
20,000
|
$0.36
|
6/25/2014
|
20,000
|
$0.37
|
6/26/2014
|
20,000
|
$0.40
|
6/27/2014
|
20,000
|
$0.38
|
6/30/2014
|
40,000
|
$0.37
|
7/1/2014
|
40,000
|
$0.36
|
7/2/2014
|
40,000
|
$0.36
|
7/3/2014
|
32,000
|
$0.36
|
7/7/2014
|
50,000
|
$0.35
|
7/8/2014
|
60,000
|
$0.35
|
7/9/2014
|
60,000
|
$0.36
|
7/10/2014
|
59,977
|
$0.35
|
7/11/2014
|
60,000
|
$0.36
|
|
July 18, 2014
|
|||||
|
|
|
|
|
||
|
|
|
|
|
||
|
BIOeCON B.V.
|
|||||
|
|
|
|
|
||
|
|
|
|
|
||
|
By: BIOeCON Holding B.V., its Managing Director
|
|||||
|
|
By:BIOeCON International Holding N.V., its Managing Director
|
||||
|
|
|
By: Orangefield Trust (Caribbean) N.V., its
|
|||
|
|
|
Managing Director
|
|||
|
|
|
|
|
||
|
|
|
|
|
||
By: | /s/ B. Bekkering | |||||
Name: | B. Bekkering | |||||
Title: | General Proxyholder | |||||
By: | /s/ E. J. Nectar | |||||
Name: | E. J. Nectar | |||||
Title: | General Proxyholder | |||||
|
|
|
By: |
/s/ O.B. de Haseth
|
|
|
|
|
|
Name: |
O.B. de Haseth
|
|
|
|
|
|
Title: |
Director
|
|
|
|
|
|
|
|
||
|
|
|
|
|
||
|
BIOeCON HOLDING B.V.
|
|||||
|
|
|
|
|
||
|
|
|
|
|
||
|
By: BIOeCON International Holding N.V., its Managing Director
|
|||||
|
|
By: Orangefield Trust (Caribbean) N.V., its Managing Director
|
|
|
|
|
|
||
By: | /s/ B. Bekkering | |||||
Name: | B. Bekkering | |||||
Title: | General Proxyholder | |||||
By: | /s/ E. J. Nectar | |||||
Name: | E. J. Nectar | |||||
Title: | General Proxyholder | |||||
|
|
|
By: |
/s/ O.B. de Haseth
|
|
|
|
|
|
Name: |
O.B. de Haseth
|
|
|
|
|
|
Title: |
Director
|
|
BIOeCON INTERNATIONAL HOLDING N.V.
|
|||||
|
|
|
|
|
||
|
|
|
|
|
||
|
By: Orangefield Trust (Caribbean) N.V., its Managing Director
|
|||||
|
|
|
|
|
||
|
|
|
|
|
||
By: | /s/ B. Bekkering | |||||
|
|
Name:
|
B. Bekkering
|
|
||
|
|
Title:
|
General Proxyholder
|
|
||
|
|
|
|
|
||
|
|
|
|
|
||
By: | /s/ E. J. Nectar | |||||
|
|
Name:
|
E. J. Nectar
|
|
||
|
|
Title:
|
General Proxyholder
|
|
||
|
|
|
|
|
||
|
|
|
|
|
||
By: | /s/ O.B. de Haseth | |||||
|
Name:
|
O.B. de Haseth
|
|
|||
|
Title:
|
Director
|
|